MoneyWorks4Me

RBI examines Lupin’s proposal to increase FII limit to 49%

17 Oct 2013 Evaluate

The Reserve Bank of India (RBI) is studying the proposal submitted by Lupin for increasing the Foreign Institutional Investors (FIIs) shareholding limit from 33% to 49%. The company has applied to RBI for its approval pursuant to the resolution passed at the last Annual General Meeting (AGM) for the same.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..